| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.95B | 148.95B | 139.24B | 124.20B | 97.78B | 93.08B |
| Gross Profit | 29.29B | 29.75B | 27.55B | 24.58B | 18.70B | 19.36B |
| EBITDA | 13.10B | 13.34B | 12.85B | 10.39B | 8.19B | 8.39B |
| Net Income | 8.92B | 16.91B | 6.67B | 2.67B | 4.21B | 8.17B |
Balance Sheet | ||||||
| Total Assets | 183.63B | 203.02B | 192.25B | 208.01B | 146.46B | 153.57B |
| Cash, Cash Equivalents and Short-Term Investments | 44.36B | 40.15B | 30.56B | 30.04B | 23.26B | 29.06B |
| Total Debt | 18.21B | 17.66B | 21.65B | 38.14B | 19.09B | 27.76B |
| Total Liabilities | 73.89B | 85.55B | 80.19B | 102.47B | 63.77B | 72.62B |
| Stockholders Equity | 92.63B | 98.19B | 93.06B | 87.35B | 81.18B | 79.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.12B | 17.71B | -7.96B | 6.17B | -13.81B |
| Operating Cash Flow | 0.00 | 5.16B | 18.46B | -5.63B | 8.23B | 812.00M |
| Investing Cash Flow | 0.00 | 27.17B | 1.43B | -2.77B | -2.82B | -5.37B |
| Financing Cash Flow | 0.00 | -21.64B | -20.47B | 7.44B | -11.56B | -628.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥97.88B | 5.90 | ― | 3.20% | 6.98% | 164.25% | |
75 Outperform | ¥993.32B | 60.50 | 6.61% | 1.58% | -1.47% | -19.46% | |
75 Outperform | ¥240.03B | 18.20 | 9.02% | 3.11% | 9.57% | 40.16% | |
73 Outperform | ¥715.64B | 24.82 | ― | 1.43% | 8.81% | 17.58% | |
64 Neutral | ¥141.90B | 15.69 | 12.54% | 1.84% | 17.17% | 33.30% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥218.76B | 20.35 | ― | 2.41% | 5.68% | -49.64% |